LifeVantage (NASDAQ:LFVN) Releases Earnings Results, Beats Estimates By $0.08 EPS

LifeVantage (NASDAQ:LFVNGet Free Report) posted its earnings results on Wednesday. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.08, Zacks reports. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%.

LifeVantage Stock Down 4.2 %

LFVN traded down $1.00 during trading on Wednesday, reaching $22.74. The company had a trading volume of 486,894 shares, compared to its average volume of 270,076. The stock has a market cap of $284.70 million, a P/E ratio of 71.06 and a beta of 0.84. The business has a 50 day simple moving average of $18.97 and a 200-day simple moving average of $13.59. LifeVantage has a 52 week low of $5.22 and a 52 week high of $27.38.

LifeVantage Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%. LifeVantage’s dividend payout ratio is presently 50.00%.

Wall Street Analysts Forecast Growth

LFVN has been the subject of a number of research reports. Craig Hallum initiated coverage on LifeVantage in a research report on Tuesday, January 14th. They set a “buy” rating and a $35.00 target price for the company. Lake Street Capital initiated coverage on LifeVantage in a research report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price target for the company.

Read Our Latest Stock Report on LifeVantage

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Articles

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.